News | January 01, 2025
Anthem Biosciences files DRHP for Rs. 3,395 crore IPO
Anthem’s business comprises of CRDMO services and the manufacture and sale of Specialty Ingredients
Anthem’s business comprises of CRDMO services and the manufacture and sale of Specialty Ingredients
The huminsulin range of products is indicated for the treatment of type 1 and type 2 diabetes mellitus to improve blood sugar control in both adults and childre
Infections with H. pylori affect over 43 percent of the world’s population with a wide range of gastrointestinal disorders
Thyrocare becomes first national diagnostic chain with 100% of its labs with NABL accreditation
The technical program will run in four sessions and a panel discussion on “Challenges in translation of medical technologies”
Divestment is part of BASF’s strategic portfolio optimization
The TPE Tourniquet and TPE Esmark Bandages are renowned for their single-use design,
The segment has immense growth potential driven by the country's increasing healthcare needs, technological innovations, government support, and emerging market opportunities
The report also revealed that 87% of physicians agreed that FEE recommendations would help to improve the speed of recovery
This facility marks a significant milestone in transforming the global food industr
Subscribe To Our Newsletter & Stay Updated
